Korean J Gastroenterol.  2024 Nov;84(5):201-205. 10.4166/kjg.2024.120.

Noninvasive Imaging Test to Assess Liver Fibrosis: Vibration-controlled Transient Elastography

• Kim MN

• KMID: 2561589
• DOI: http://doi.org/10.4166/kjg.2024.120

Abstract

Liver fibrosis refers to the formation of scar tissue in the liver when inflammation persists over a long period. Assessing liver fibrosis is crucial for predicting the prognosis of chronic liver disease and managing patients with these conditions. Although a liver biopsy remains the gold standard for assessing liver fibrosis, it is limited by its invasive nature. Consequently, continuous efforts have been made to develop non-invasive methods for evaluating liver fibrosis, including imaging techniques and serum biomarkers. Vibration-controlled transient elastography (VCTE), a representative non-invasive imaging technique, has been used widely for liver fibrosis assessment since its introduction in 2003. This paper discusses the principles and methods of measurement, the advantages and disadvantages, and the considerations for interpreting VCTE based on the 2024 KASL Clinical Practice Guidelines for Non-invasive Tests to Assess Liver Fibrosis in Chronic Liver Disease. In addition, the diagnostic utility of VCTE in chronic viral hepatitis is reviewed.

Keyword

Noninvasive test; Liver fibrosis; Chronic liver disease; Vibration-controlled transient elastography

Figure

• 

  Fig. 1 Principles of vibration-controlled transient elastography.

Reference

1. Kim MN, Han JW, An J, et al. 2024; KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease. Clin Mol Hepatol. 30(Suppl):S5–S105. DOI: 10.3350/cmh.2024.0506. PMID: 39159947. PMCID: PMC11493350.

2. Horowitz JM, Venkatesh SK, Ehman RL, et al. 2017; Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY). 42:2037–2053. DOI: 10.1007/s00261-017-1211-7. PMID: 28624924. PMCID: PMC5994771.

3. Tang A, Cloutier G, Szeverenyi NM, Sirlin CB. 2015; Ultrasound elastography and MR elastography for assessing liver fibrosis: Part 1, principles and techniques. AJR Am J Roentgenol. 205:22–32. DOI: 10.2214/AJR.15.14552. PMID: 25905647. PMCID: PMC4819982.

4. Barr RG, Ferraioli G, Palmeri ML, et al. 2015; Elastography assessment of liver fibrosis: Society of radiologists in ultrasound consensus conference statement. Radiology. 276:845–861. DOI: 10.1148/radiol.2015150619. PMID: 26079489.

5. Sandrin L, Fourquet B, Hasquenoph JM, et al. 2003; Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 29:1705–1713. DOI: 10.1016/j.ultrasmedbio.2003.07.001. PMID: 14698338.

6. Choi BI. 2022; Ultrasound elastography for liver disease with focus on hepatic fibrosis. Clin Ultrasound. 7:1–10. DOI: 10.18525/cu.2022.7.1.1.

7. Shiina T, Nightingale KR, Palmeri ML, et al. 2015; WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 1: basic principles and terminology. Ultrasound Med Biol. 41:1126–1147. DOI: 10.1016/j.ultrasmedbio.2015.03.009. PMID: 25805059.

8. Oliveri F, Coco B, Ciccorossi P, et al. 2008; Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. World J Gastroenterol. 14:6154–6162. DOI: 10.3748/wjg.14.6154. PMID: 18985805. PMCID: PMC2761576.

9. Mederacke I, Wursthorn K, Kirschner J, et al. 2009; Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver Int. 29:1500–1506. DOI: 10.1111/j.1478-3231.2009.02100.x. PMID: 19732330.

10. Kim SU, Kim JK, Park JY, et al. 2009; Variability in liver stiffness values from different intercostal spaces. Liver Int. 29:760–766. DOI: 10.1111/j.1478-3231.2009.02035.x. PMID: 19413672.

11. Kim SU, Han KH, Ahn SH. 2010; Transient elastography in chronic hepatitis B: an Asian perspective. World J Gastroenterol. 16:5173–5180. DOI: 10.3748/wjg.v16.i41.5173. PMID: 21049551. PMCID: PMC2975088.

12. Lucidarme D, Foucher J, Le Bail B, et al. 2009; Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology. 49:1083–1089. DOI: 10.1002/hep.22748. PMID: 19140221.

13. Myers RP, Crotty P, Pomier-Layrargues G, Ma M, Urbanski SJ, Elkashab M. 2010; Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. Liver Int. 30:1471–1480. DOI: 10.1111/j.1478-3231.2010.02331.x. PMID: 20807336.

14. Sagir A, Erhardt A, Schmitt M, Häussinger D. 2008; Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology. 47:592–595. DOI: 10.1002/hep.22056. PMID: 18098325.

15. Arena U, Vizzutti F, Corti G, et al. 2008; Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 47:380–384. DOI: 10.1002/hep.22007. PMID: 18095306.

16. Coco B, Oliveri F, Maina AM, et al. 2007; Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 14:360–369. DOI: 10.1111/j.1365-2893.2006.00811.x. PMID: 17439526.

17. Kim SU, Kim DY, Park JY, et al. 2010; How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B? J Clin Gastroenterol. 44:66–71. DOI: 10.1097/MCG.0b013e3181a95c7f. PMID: 19609218.

18. Millonig G, Reimann FM, Friedrich S, et al. 2008; Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology. 48:1718–1723. DOI: 10.1002/hep.22577. PMID: 18836992.

19. Millonig G, Friedrich S, Adolf S, et al. 2010; Liver stiffness is directly influenced by central venous pressure. J Hepatol. 52:206–210. DOI: 10.1016/j.jhep.2009.11.018. PMID: 20022130.

20. Bardou-Jacquet E, Legros L, Soro D, et al. 2013; Effect of alcohol consumption on liver stiffness measured by transient elastography. World J Gastroenterol. 19:516–522. DOI: 10.3748/wjg.v19.i4.516. PMID: 23382630. PMCID: PMC3558575.

21. Mueller S, Millonig G, Sarovska L, et al. 2010; Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol. 16:966–972. DOI: 10.3748/wjg.v16.i8.966. PMID: 20180235. PMCID: PMC2828601.

22. Trabut JB, Thépot V, Nalpas B, et al. 2012; Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers. Alcohol Clin Exp Res. 36:1407–1411. DOI: 10.1111/j.1530-0277.2012.01737.x. PMID: 22404692.

23. Marcellin P, Ziol M, Bedossa P, et al. 2009; Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int. 29:242–247. DOI: 10.1111/j.1478-3231.2008.01802.x. PMID: 18637064.

24. Chan HL, Wong GL, Choi PC, et al. 2009; Alanine aminotransferasebased algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat. 16:36–44. DOI: 10.1111/j.1365-2893.2008.01037.x. PMID: 18673426.

25. Kim BK, Kim SU, Kim HS, et al. 2012; Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B. PLoS One. 7:e35825. DOI: 10.1371/journal.pone.0035825. PMID: 22536445. PMCID: PMC3335013.

26. Zhu X, Wang LC, Chen EQ, et al. 2011; Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection. Dig Dis Sci. 56:2742–2749. DOI: 10.1007/s10620-011-1659-1. PMID: 21399926.

27. Degos F, Perez P, Roche B, et al. 2010; Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol. 53:1013–1021. DOI: 10.1016/j.jhep.2010.05.035. PMID: 20850886.

28. Sporea I, Sirli R, Deleanu A, et al. 2010; Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative study. World J Gastroenterol. 16:4832–4837. DOI: 10.3748/wjg.v16.i38.4832. PMID: 20939112. PMCID: PMC2955253.

29. Viganò M, Paggi S, Lampertico P, et al. 2011; Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation. Aliment Pharmacol Ther. 34:353–362. DOI: 10.1111/j.1365-2036.2011.04722.x. PMID: 21631559.

30. Verveer C, Zondervan PE, ten Kate FJ, Hansen BE, Janssen HL, de Knegt RJ. 2012; Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver Int. 32:622–628. DOI: 10.1111/j.1478-3231.2011.02663.x. PMID: 22098684.

31. Cardoso AC, Carvalho-Filho RJ, Stern C, et al. 2012; Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int. 32:612–621. DOI: 10.1111/j.1478-3231.2011.02660.x. PMID: 22103765.

32. Chon YE, Choi EH, Song KJ, et al. 2012; Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis. PLoS One. 7:e44930. DOI: 10.1371/journal.pone.0044930. PMID: 23049764. PMCID: PMC3458028.

33. Li Y, Huang YS, Wang ZZ, et al. 2016; Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B. Aliment Pharmacol Ther. 43:458–469. DOI: 10.1111/apt.13488. PMID: 26669632.

34. Qi X, An M, Wu T, et al. 2018; Transient elastography for significant liver fibrosis and cirrhosis in chronic hepatitis B: A meta-analysis. Can J Gastroenterol Hepatol. 2018:3406789. DOI: 10.1155/2018/3406789. PMID: 29977884. PMCID: PMC5994263.

35. Mingkai L, Sizhe W, Xiaoying W, Ying L, Wu B. 2022; Diagnostic performance of elastography on liver fibrosis in antiviral treatment-naive chronic hepatitis B patients: a meta-analysis. Gastroenterol Rep (Oxf). 10:goac005. DOI: 10.1093/gastro/goac005. PMID: 35186298. PMCID: PMC8849285.

36. Fraquelli M, Rigamonti C, Casazza G, et al. 2011; Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. J Hepatol. 54:621–628. DOI: 10.1016/j.jhep.2010.07.017. PMID: 21146243.

37. European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. 2015; EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 63:237–264. DOI: 10.1016/j.jhep.2015.04.006. PMID: 25911335.

38. Kim MN, An J, Kim EH, et al. 2024; Vibration-controlled transient elastography for significant fibrosis in treatment-naïve chronic hepatitis B patients: A systematic review and meta-analysis. Clin Mol Hepatol. 30(Suppl):S106–S116. DOI: 10.3350/cmh.2024.0371. PMID: 39043361. PMCID: PMC11493358.

39. Ziol M, Handra-Luca A, Kettaneh A, et al. 2005; Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 41:48–54. DOI: 10.1002/hep.20506. PMID: 15690481.

40. Poynard T, de Ledinghen V, Zarski JP, et al. 2012; Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard. J Hepatol. 56:541–548. DOI: 10.1016/j.jhep.2011.08.007. PMID: 21889468.

41. Seo YS, Kim MY, Kim SU, et al. 2015; Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study. Liver Int. 35:2246–2255. DOI: 10.1111/liv.12808. PMID: 25682719.